NEW YORK (GenomeWeb News) – The National Institutes of Health sees metabolomics as a discipline with great potential for the study and treatment of disease, and said today that it plans to invest as much as $51.4 million over five years to bolster this new field through the NIH Common Fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.